Search research articles
Contact Us
Filters
Showing results (171-180 of 415) with videos related to
Page
of 42
Sort By:
Lupus
|
August 17, 2024
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls
Valérie Lbi Jansen, Mark Davids, Dagmar Jm van Mourik, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
November 6, 2020
Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program
Arnold W J M van de Laar, Victor E A Gerdes, Roeland Huijgen, et al.
Metabolites
|
December 23, 2021
Physical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort-The HELIUS Study
Veera Houttu, Ulrika Boulund, Mary Nicolaou, et al.
Obesity Surgery
|
June 12, 2026
What is Weight Loss after Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? An Updated Systematic Review
Rutger Franken, Felix Hers, Redouan El Ajraoui, et al.
Computer Methods and Programs in Biomedicine
|
September 26, 2024
Does GLP-1 cause post-bariatric hypoglycemia: 'Computer says no'
Ysanne M Pasveer, Ömrüm Aydin, Albert K Groen, et al.
Scientific Reports
|
May 7, 2020
Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males
Gerben D A Hermes, Dorien Reijnders, Ruud S Kootte, et al.
Diabetes, Obesity & Metabolism
|
May 2, 2022
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial
Charlotte C van Ruiten, Dick J Veltman, Madelief Wijdeveld, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2019
Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?
Rosalie A Scholtes, Michaël J B van Baar, Yuliya Lytvyn, et al.
Frontiers in Clinical Diabetes and Healthcare
|
March 30, 2023
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
Suzanne Meiring, Annieke C G van Baar, Nikolaj Sørensen, et al.
Frontiers in Endocrinology
|
September 21, 2023
Genetic glucocorticoid receptor variants differ between ethnic groups but do not explain variation in age of diabetes onset, metabolic and inflammation parameters in patients with type 2 diabetes
Mohamed Ahdi, Maaike C Gerards, Paul H M Smits, et al.
Page
of 42
Search research articles
Search
Showing results (171-180 of 415) with videos related to
Sort By:
Page
of 42
Lupus
|
August 17, 2024
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls
Valérie Lbi Jansen, Mark Davids, Dagmar Jm van Mourik, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
November 6, 2020
Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program
Arnold W J M van de Laar, Victor E A Gerdes, Roeland Huijgen, et al.
Metabolites
|
December 23, 2021
Physical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort-The HELIUS Study
Veera Houttu, Ulrika Boulund, Mary Nicolaou, et al.
Obesity Surgery
|
June 12, 2026
What is Weight Loss after Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? An Updated Systematic Review
Rutger Franken, Felix Hers, Redouan El Ajraoui, et al.
Computer Methods and Programs in Biomedicine
|
September 26, 2024
Does GLP-1 cause post-bariatric hypoglycemia: 'Computer says no'
Ysanne M Pasveer, Ömrüm Aydin, Albert K Groen, et al.
Scientific Reports
|
May 7, 2020
Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males
Gerben D A Hermes, Dorien Reijnders, Ruud S Kootte, et al.
Diabetes, Obesity & Metabolism
|
May 2, 2022
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial
Charlotte C van Ruiten, Dick J Veltman, Madelief Wijdeveld, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2019
Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?
Rosalie A Scholtes, Michaël J B van Baar, Yuliya Lytvyn, et al.
Frontiers in Clinical Diabetes and Healthcare
|
March 30, 2023
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
Suzanne Meiring, Annieke C G van Baar, Nikolaj Sørensen, et al.
Frontiers in Endocrinology
|
September 21, 2023
Genetic glucocorticoid receptor variants differ between ethnic groups but do not explain variation in age of diabetes onset, metabolic and inflammation parameters in patients with type 2 diabetes
Mohamed Ahdi, Maaike C Gerards, Paul H M Smits, et al.
Page
of 42